BioCentury
ARTICLE | Clinical News

CoStasis and DynaStat surgical hemostats regulatory update

July 3, 2000 7:00 AM UTC

The FDA granted marketing clearance for CSON's CoStasis surgical hemostat used to stop or control active bleeding during general, hepatic and cardiovascular surgeries. The FDA also granted clearance t...